DnB Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,444
Closed -$461K 771
2025
Q1
$461K Sell
10,444
-1,431
-12% -$65.9K ﹤0.01% 662
2024
Q4
$429K Sell
11,875
-529
-4% -$18.5K ﹤0.01% 671
2024
Q3
$397K Buy
12,404
+1,002
+9% +$37.4K ﹤0.01% 667
2024
Q2
$429K Buy
11,402
+1,617
+17% +$68.1K ﹤0.01% 661
2024
Q1
$482K Sell
9,785
-2,225
-19% -$103K ﹤0.01% 654
2023
Q4
$438K Buy
12,010
+24
+0.2% +$626 ﹤0.01% 631
2023
Q3
$277K Sell
11,986
-2,825
-19% -$77.3K ﹤0.01% 653
2023
Q2
$388K Buy
14,811
+4,568
+45% +$120K ﹤0.01% 643
2023
Q1
$264K Buy
10,243
+52
+0.5% +$1.52K ﹤0.01% 642
2022
Q4
$265K Buy
+10,191
New +$251K ﹤0.01% 630

Other funds holding SWTX